The role of interleukin-17 in spondyloarthropathies and systemic lupus erythematosus: Two clinical cases in real
<p>Spondyloarthropathies are known to affect the interleukin (IL)-17 activation pathway as a basis of their pathology, as is apparent from the literature. Recent studies established the vital role of IL-17 in the treatment of Systemic Lupus Erythematosus (SLE). This article aims to demonstrate...
Saved in:
Main Authors: | Paula Antunes (Author), Rita Costa (Author), Ana Gorgulho (Author), António Marinho (Author) |
---|---|
Format: | Book |
Published: |
Global Journal of Medical and Clinical Case Reports - Peertechz Publications,
2022-01-19.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Interleukin- (IL-) 17 in the Pathogenesis and Targeted Therapies in Spondyloarthropathies
by: I-Tsu Chyuan, et al.
Published: (2018) -
The expression of interleukin-17 in cutaneous lesions of lupus erythematosus in pediatric-onset systemic lupus erythematosus
by: Govind Suresh Mittal, et al.
Published: (2017) -
Interleukin-6 and disease activity in childhood systemic lupus erythematosus
by: Cahya Dewi Satria, et al.
Published: (2023) -
Ratio of Th17/Treg and Disease Activity in Systemic Lupus Erythematosus
by: Yuliasih Yuliasih, et al.
Published: (2019) -
The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity
by: W.A. Wan Asyraf, et al.
Published: (2018)